Journal of Nuclear Cardiology

, Volume 1, Issue 2, pp 210–212 | Cite as

Research in cardiac nuclear medicine: The difficult but critical next step

  • Lee Goldman
Challenge Editorials

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Alexander JA, Dainiak N, Berger HJ, et al. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. N Engl J Med 1979;300:278–83.PubMedGoogle Scholar
  2. 2.
    Wackers FJ, Berger HJ, Johnstone DE, et al. Multiple gated cardiac blood pool imaging for left ventricular ejection fraction: validation of the technique and assessment of variability. Am J Cardiol 1979;43:1159–66.PubMedCrossRefGoogle Scholar
  3. 3.
    Goldman L, Feinstein AR, Batsford WP, Cohen LS, Gottschalk A, Zaret BL. Ordering patterns and clinical impact of cardiovascular nuclear medicine procedures. Circulation 1980;62:680–7.PubMedGoogle Scholar
  4. 4.
    Hamm CW, Ravkilde J, Gerhardt W, et al. The prognostic value of serum Troponin T in unstable angina. N Engl J Med 1992;327:146–50.PubMedGoogle Scholar
  5. 5.
    Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406–12.Google Scholar
  6. 6.
    Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 1991;325:1468–75.PubMedGoogle Scholar

Copyright information

© American Society of Nuclear Cardiology 1994

Authors and Affiliations

  • Lee Goldman
    • 1
  1. 1.Section of Clinical Epidemiology, Department of MedicineBrigham and Women’s HospitalBoston

Personalised recommendations